| 02/06/16 | 18:26:21 | 2 Jun 2016 | | Director/PDMR Shareholding | RNS |
| 31/05/16 | 11:38:17 | 31 May 2016 | | Holding(s) in Company | RNS |
| 26/05/16 | 15:00:25 | 26 May 2016 | | Result of AGM | RNS |
| 25/05/16 | 08:00:12 | 25 May 2016 | | Holding(s) in Company | RNS |
| 04/05/16 | 08:01:03 | 4 May 2016 | | Annual Financial Report & Notice of AGM | RNS |
| 04/05/16 | 08:00:08 | 4 May 2016 | | Final Results | RNS |
| 26/04/16 | 08:00:10 | 26 Apr 2016 | | Notice of Results | RNS |
| 22/04/16 | 10:50:58 | 22 Apr 2016 | | Holding(s) in Company | RNS |
| 09/03/16 | 07:00:07 | 9 Mar 2016 | | First European Site Opens - Patient Recruitment | RNS |
| 08/03/16 | 11:10:59 | 8 Mar 2016 | | Holding(s) in Company | RNS |
| 07/03/16 | 15:31:11 | 7 Mar 2016 | | Holding(s) in Company | RNS |
| 01/03/16 | 07:00:11 | 1 Mar 2016 | | EIS and VCT Qualifying Status and Issue of Equity | RNS |
| 29/02/16 | 08:02:34 | 29 Feb 2016 | | Holding(s) in Company | RNS |
| 24/02/16 | 12:35:50 | 24 Feb 2016 | | Issue of Equity | RNS |
| 22/02/16 | 13:39:36 | 22 Feb 2016 | | Result of GM | RNS |
| 15/02/16 | 07:00:08 | 15 Feb 2016 | | US PATIENTS COMMENCE DOSING IN PHASE III STUDY | RNS |
| 05/02/16 | 12:22:09 | 5 Feb 2016 | | Placing and Subscription Raises £8.3 million | RNS |
| 05/02/16 | 07:00:06 | 5 Feb 2016 | | Proposed Placing and Subscription | RNS |
| 21/01/16 | 17:33:55 | 21 Jan 2016 | | Holding(s) in Company | RNS |
| 15/12/15 | 07:00:06 | 15 Dec 2015 | | ImmuPharma & Simbec-Orion - Investigators Meeting | RNS |
| 07/12/15 | 07:00:07 | 7 Dec 2015 | | Update on the progress of Lupuzor | RNS |
| 30/11/15 | 11:55:26 | 30 Nov 2015 | | Holding(s) in Company | RNS |
| 04/11/15 | 08:26:45 | 4 Nov 2015 | | Lupuzor Phase III Pivotal Trial Update | RNS |
| 04/11/15 | 07:00:06 | 4 Nov 2015 | | Lupuzor Phase III Pivotal Trial Update | RNS |
| 23/10/15 | 08:00:06 | 23 Oct 2015 | | Directorate Change | RNS |
| 30/09/15 | 08:05:02 | 30 Sept 2015 | | Directorate Change | RNS |
| 30/09/15 | 08:00:15 | 30 Sept 2015 | | Interim Results | RNS |
| 29/07/15 | 08:00:18 | 29 Jul 2015 | | Richard Warr | RNS |
| 27/07/15 | 08:00:13 | 27 Jul 2015 | | TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR | RNS |
| 29/05/15 | 13:50:44 | 29 May 2015 | | Result of AGM | RNS |
| 06/05/15 | 16:44:46 | 6 May 2015 | | Annual Report & Accounts | RNS |
| 06/05/15 | 08:02:07 | 6 May 2015 | | Interim Board Change | RNS |
| 30/04/15 | 08:05:02 | 30 Apr 2015 | | Directorate Change | RNS |
| 30/04/15 | 08:00:14 | 30 Apr 2015 | | Preliminary Results | RNS |
| 11/02/15 | 12:02:59 | 11 Feb 2015 | | CANCER UPDATE: IPP-204106 | RNS |
| 27/01/15 | 07:00:52 | 27 Jan 2015 | | Enterprise Investment Scheme Status | RNS |
| 22/01/15 | 07:00:22 | 22 Jan 2015 | | Collaboration Agreement with Simbec-Orion | RNS |
| 30/10/14 | 11:10:47 | 30 Oct 2014 | | Holding(s) in Company | RNS |
| 28/10/14 | 07:00:08 | 28 Oct 2014 | | Holding(s) in Company | RNS |
| 21/10/14 | 08:00:23 | 21 Oct 2014 | | Additional Listing - Conditional Placing | RNS |
| 20/10/14 | 08:00:07 | 20 Oct 2014 | | ImmuPharma awarded EUR400,000 Grant | RNS |
| 30/09/14 | 08:05:03 | 30 Sept 2014 | | Half Yearly Report | RNS |
| 30/09/14 | 08:00:38 | 30 Sept 2014 | | LupuzorT Gears Up To Start Pivotal Phase III trial | RNS |
| 27/06/14 | 14:11:27 | 27 Jun 2014 | | Result of AGM | RNS |
| 27/06/14 | 08:00:07 | 27 Jun 2014 | | Access to pioneering research in Bordeaux France | RNS |
| 16/06/14 | 08:00:14 | 16 Jun 2014 | | NEW NUCANT PATENTS | RNS |
| 23/05/14 | 08:00:10 | 23 May 2014 | | Annual Financial Report | RNS |
| 21/05/14 | 08:00:15 | 21 May 2014 | | Preliminary Results | RNS |
| 14/10/13 | 08:00:07 | 14 Oct 2013 | | Additional Listing | RNS |
| 27/09/13 | 08:00:14 | 27 Sept 2013 | | Half Yearly Report | RNS |
